Gayle M Wittenberg1, Jon Greene2, Petra E Vértes3, Wayne C Drevets4, Edward T Bullmore5. 1. Neuroscience, Janssen Research & Development, LLC, Titusville, New Jersey. 2. Bioinformatics, Rancho BioSciences, LLC, San Diego, California. 3. Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Alan Turing Institute, London, United Kingdom. 4. Neuroscience, Janssen Research & Development, LLC, San Diego, California. 5. Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge, United Kingdom. Electronic address: etb23@cam.ac.uk.
Abstract
BACKGROUND: Whole-genome transcription has been measured in peripheral blood samples as a candidate biomarker of inflammation associated with major depressive disorder. METHODS: We searched for all case-control studies on major depressive disorder that reported microarray or RNA sequencing measurements on whole blood or peripheral blood mononuclear cells. Primary datasets were reanalyzed, when openly accessible, to estimate case-control differences and to evaluate the functional roles of differentially expressed gene lists by technically harmonized methods. RESULTS: We found 10 eligible studies (N = 1754 depressed cases and N = 1145 healthy controls). Fifty-two genes were called significant by 2 of the primary studies (published overlap list). After harmonization of analysis across 8 accessible datasets (n = 1706 cases, n = 1098 controls), 272 genes were coincidentally listed in the top 3% most differentially expressed genes in 2 or more studies of whole blood or peripheral blood mononuclear cells with concordant direction of effect (harmonized overlap list). By meta-analysis of standardized mean difference across 4 studies of whole-blood samples (n = 1567 cases, n = 954 controls), 343 genes were found with false discovery rate <5% (standardized mean difference meta-analysis list). These 3 lists intersected significantly. Genes abnormally expressed in major depressive disorder were enriched for innate immune-related functions, coded for nonrandom protein-protein interaction networks, and coexpressed in the normative transcriptome module specialized for innate immune and neutrophil functions. CONCLUSIONS: Quantitative review of existing case-control data provided robust evidence for abnormal expression of gene networks important for the regulation and implementation of innate immune response. Further development of white blood cell transcriptional biomarkers for inflamed depression seems warranted.
BACKGROUND: Whole-genome transcription has been measured in peripheral blood samples as a candidate biomarker of inflammation associated with major depressive disorder. METHODS: We searched for all case-control studies on major depressive disorder that reported microarray or RNA sequencing measurements on whole blood or peripheral blood mononuclear cells. Primary datasets were reanalyzed, when openly accessible, to estimate case-control differences and to evaluate the functional roles of differentially expressed gene lists by technically harmonized methods. RESULTS: We found 10 eligible studies (N = 1754 depressed cases and N = 1145 healthy controls). Fifty-two genes were called significant by 2 of the primary studies (published overlap list). After harmonization of analysis across 8 accessible datasets (n = 1706 cases, n = 1098 controls), 272 genes were coincidentally listed in the top 3% most differentially expressed genes in 2 or more studies of whole blood or peripheral blood mononuclear cells with concordant direction of effect (harmonized overlap list). By meta-analysis of standardized mean difference across 4 studies of whole-blood samples (n = 1567 cases, n = 954 controls), 343 genes were found with false discovery rate <5% (standardized mean difference meta-analysis list). These 3 lists intersected significantly. Genes abnormally expressed in major depressive disorder were enriched for innate immune-related functions, coded for nonrandom protein-protein interaction networks, and coexpressed in the normative transcriptome module specialized for innate immune and neutrophil functions. CONCLUSIONS: Quantitative review of existing case-control data provided robust evidence for abnormal expression of gene networks important for the regulation and implementation of innate immune response. Further development of white blood cell transcriptional biomarkers for inflamed depression seems warranted.
Authors: Galen Missig; Emma L Fritsch; Niyati Mehta; Miles E Damon; Erica M Jarrell; Andrew A Bartlett; F Ivy Carroll; William A Carlezon Journal: Pharmacol Biochem Behav Date: 2021-11-23 Impact factor: 3.533
Authors: Carina Seah; Michael S Breen; Tom Rusielewicz; Heather N Bader; Changxin Xu; Christopher J Hunter; Barry McCarthy; P J Michael Deans; Mitali Chattopadhyay; Jordan Goldberg; Frank Desarnaud; Iouri Makotkine; Janine D Flory; Linda M Bierer; Migle Staniskyte; Scott A Noggle; Laura M Huckins; Daniel Paull; Kristen J Brennand; Rachel Yehuda Journal: Nat Neurosci Date: 2022-10-20 Impact factor: 28.771
Authors: Valeria Mondelli; Annamaria Cattaneo; Naghmeh Nikkheslat; Laila Souza; Annabel Walsh; Zuzanna Zajkowska; Valentina Zonca; Moira Marizzoni; Helen L Fisher; Brandon A Kohrt; Christian Kieling; Paola Di Meglio Journal: Brain Behav Immun Health Date: 2021-11-27
Authors: Deepti Singh; Paul C Guest; Henrik Dobrowolny; Veronika Vasilevska; Gabriela Meyer-Lotz; Hans-Gert Bernstein; Katrin Borucki; Alexandra Neyazi; Bernhard Bogerts; Roland Jacobs; Johann Steiner Journal: J Neuroinflammation Date: 2022-04-04 Impact factor: 8.322